Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy C Nichols

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Veterinary Journal (London, England : 1997)|January 11, 2011
Canine specific ELISA for coagulation factor VIITom Knudsen, Mads Kjelgaard-Hansen, Mikael Tranholm, et al.
Blood|December 26, 2008
Successful treatment of canine hemophilia by continuous expression of canine FVIIaParis Margaritis, Elise Roy, Majed N Aljamali, et al.
Gene Therapy|October 2, 2019
Superior human hepatocyte transduction with adeno-associated virus vector serotype 7Wenwei Shao, Xiaolei Pei, Caibin Cui, et al.
Cancer & Metabolism|November 28, 2013
Monitoring metabolic responses to chemotherapy in single cells and tumors using nanostructure-initiator mass spectrometry (NIMS) imagingPeter J O'Brien, Michelle Lee, Mary E Spilker, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 9, 2002
Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injuryJoseph Pye, Farhad Ardeshirpour, Arlene McCain, et al.
Plos One|April 3, 2014
Targeted disruption of LDLR causes hypercholesterolemia and atherosclerosis in Yucatan miniature pigsBryan T Davis, Xiao-Jun Wang, Judy A Rohret, et al.
Oncogene|February 1, 2019
Combining CDK4/6 inhibition with taxanes enhances anti-tumor efficacy by sustained impairment of pRB-E2F pathways in squamous cell lung cancerJoan Cao, Zhou Zhu, Hui Wang, et al.
Human Gene Therapy|August 7, 2002
Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapyRoland W Herzog, Paul A Fields, Valder R Arruda, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2010
Efficacy and safety of long-term prophylaxis in severe hemophilia A dogs following liver gene therapy using AAV vectorsDenise E Sabatino, Amy M Lange, Ekaterina S Altynova, et al.
Molecular Therapy. Methods & Clinical Development|February 20, 2024
AAV gene therapy in companion dogs with severe hemophilia: Real-world long-term data on immunogenicity, efficacy, and quality of lifeBhavya S Doshi, Benjamin J Samelson-Jones, Timothy C Nichols, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Veterinary Journal (London, England : 1997)|January 11, 2011
Canine specific ELISA for coagulation factor VIITom Knudsen, Mads Kjelgaard-Hansen, Mikael Tranholm, et al.
Blood|December 26, 2008
Successful treatment of canine hemophilia by continuous expression of canine FVIIaParis Margaritis, Elise Roy, Majed N Aljamali, et al.
Gene Therapy|October 2, 2019
Superior human hepatocyte transduction with adeno-associated virus vector serotype 7Wenwei Shao, Xiaolei Pei, Caibin Cui, et al.
Cancer & Metabolism|November 28, 2013
Monitoring metabolic responses to chemotherapy in single cells and tumors using nanostructure-initiator mass spectrometry (NIMS) imagingPeter J O'Brien, Michelle Lee, Mary E Spilker, et al.
American Journal of Physiology. Heart and Circulatory Physiology|November 9, 2002
Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injuryJoseph Pye, Farhad Ardeshirpour, Arlene McCain, et al.
Plos One|April 3, 2014
Targeted disruption of LDLR causes hypercholesterolemia and atherosclerosis in Yucatan miniature pigsBryan T Davis, Xiao-Jun Wang, Judy A Rohret, et al.
Oncogene|February 1, 2019
Combining CDK4/6 inhibition with taxanes enhances anti-tumor efficacy by sustained impairment of pRB-E2F pathways in squamous cell lung cancerJoan Cao, Zhou Zhu, Hui Wang, et al.
Human Gene Therapy|August 7, 2002
Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapyRoland W Herzog, Paul A Fields, Valder R Arruda, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2010
Efficacy and safety of long-term prophylaxis in severe hemophilia A dogs following liver gene therapy using AAV vectorsDenise E Sabatino, Amy M Lange, Ekaterina S Altynova, et al.
Molecular Therapy. Methods & Clinical Development|February 20, 2024
AAV gene therapy in companion dogs with severe hemophilia: Real-world long-term data on immunogenicity, efficacy, and quality of lifeBhavya S Doshi, Benjamin J Samelson-Jones, Timothy C Nichols, et al.
Pageof 11